40 research outputs found
PCN169 REVIEW OF THE DECISIONS OF HEALTH TECHNOLOGY ASSESSMENT AGENCIES FOR CAPECITABINE FOR THE TREATMENT OF BREAST CANCER
Get PDFPAR14 COST MINIMIZATION ANALYSIS OF RITUXIMAB VERSUS INFLIXIMAB, ADALIMUMAB AND ETANERCEPT FOR RHEUMATOID ARTHRITIS FROM A PAYER PERSPECTIVE IN BRAZIL
Get PDFPCN53 COST PER DISEASE STAGE OF ADVANCED GASTRIC CANCER IN BRAZIL FROM THE PRIVATE PAYER PERSPECTIVE
Get PDFPIN30 COST-MINIMIZATION ANALYSIS OF ORALVALGANCICLOVIR VERSUS INTRAVENOUS GANCICLOVIR FORTHE PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION IN SOLID ORGAN TRANSPLANT RECIPIENTS IN BRAZIL
Get PDFPIN14 COST-EFFECTIVENESS OF PEGINTERFERON-ALFA-2A (40 KD) ASSOCIATED WITH RIBAVIRIN IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C IN BRAZIL UNDER THE PRIVATE HEALTH CARE SYSTEM
Get PDFPUK5 THE IMPACT ON COSTS OF TREATING COMPLICATIONS DUE TO CRONIC KIDNEY DISEASE IN PATIENTS UNDERGOING HEMODIALYSIS IN THE PRIVATE HEALTH CARE SYSTEM IN BRAZIL
No full textPHP28 A COMPARISON OF HIGH-COST HEALTH CARE PROGRAMS AVAILABLE IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM
No full textPMS2 ANÁLISE DE CUSTOS DE RITUXIMABE VERSUS INFLIXIMABE, ADALIMUMABE, ETANERCEPTE E ABATACEPTE PARA TRATAMENTO DA ARTRITE REUMATÓIDE SOB A PERSPECTIVA DE UM PAGADOR PRIVADO NO BRASIL
No full textPHP42 THE ANNUAL HEALTH CARE EXPENDITURES PER CAPITA IN BRAZIL: A COMPARISON BETWEEN THE PUBLIC AND THE PRIVATE HEALTH CARE SYSTEMS
No full textPUK4 THE IMPACT ON COSTS OF TREATING COMPLICATIONS DUE TO CRONIC KIDNEY DISEASE IN PATIENTS UNDERGOING HEMODIALYSIS IN THE PUBLIC HEALTH CARE SYSTEM IN BRAZIL
No full text
